Coupled with the half-life of S100B being in the range of 60 to 120 minutes in patients with brain injury, the measured net amount of S100B in serum samples will inevitably be less than the original concentration due to the rate of degradation when using ELISA methodology (30). Here, S100B is linked to injury.